Oxymetazoline: Difference between revisions
| Line 3: | Line 3: | ||
*Dosage Forms: Solution; Nasal spray | *Dosage Forms: Solution; Nasal spray | ||
*Routes of Administration: Intranasal | *Routes of Administration: Intranasal | ||
*Common Trade Names: 12-Hour Nasal Relieve Spray, Afrin, Mucinex | *Common Trade Names: 12-Hour Nasal Relieve Spray, Afrin, Mucinex, Distran, Neo-synephrine | ||
==Adult Dosing== | ==Adult Dosing== | ||
Revision as of 19:05, 12 August 2016
Administration
- Type: Decongestant; Adrenergic Agonist Agent; Imidazoline derivative
- Dosage Forms: Solution; Nasal spray
- Routes of Administration: Intranasal
- Common Trade Names: 12-Hour Nasal Relieve Spray, Afrin, Mucinex, Distran, Neo-synephrine
Adult Dosing
- Instill 2-3 sprays for each nostrils twice daily for ≤3 days
Pediatric Dosing
- Children ≥6 years: Instill 2-3 sprays for each nostrils twice daily for ≤3 days
Special Populations
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: